Evidence map›Paper›PMID 24391948›Full record

ArticlePloS one2013

Microarray data reveal relationship between Jag1 and Ddr1 in mouse liver.

Lara A Underkoffler, Erikka Carr, Anthony Nelson, Matthew J Ryan, Reiner Schulz, Reiner Schultz, Kathleen M Loomes

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

  • Erratum issued
    Schultz, Reiner [corrected to Schulz, Reiner]
5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lara A UnderkofflerDivision of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Erikka CarrDivision of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Anthony NelsonDivision of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Matthew J RyanDivision of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America ; Department of Pediatrics, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Reiner Schulz
Reiner SchultzDepartment of Medical Genetics, Kings College, London, United Kingdom.
Kathleen M LoomesDivision of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America ; Department of Pediatrics, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · USKing's College London · GB

Funding

The Role of the Notch Pathway in Bile Duct DevelopmentR01DK071841 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI LOOMES, KATHLEEN MARY · 2005 to 2010
$1.8M
NIDDK NIH HHS NIH R01 DK071841NIDDK NIH HHS R01 DK071841
6 · The paper itself

Abstract

Alagille syndrome is an autosomal dominant disorder involving bile duct paucity and cholestasis in addition to cardiac, skeletal, ophthalmologic, renal and vascular manifestations. Mutations in JAG1, encoding a ligand in the Notch signaling pathway, are found in 95% of patients meeting clinical criteria for Alagille syndrome. In order to define the role of Jag1 in the bile duct developmental abnormalities seen in ALGS, we previously created a Jag1 conditional knockout mouse model. Mice heterozygous for the Jag1 conditional and null alleles demonstrate abnormalities in postnatal bile duct growth and remodeling, with portal expansion and increased numbers of malformed bile ducts. In this study we report the results of microarray analysis and identify genes and pathways differentially expressed in the Jag1 conditional/null livers as compared with littermate controls. In the initial microarray analysis, we found that many of the genes up-regulated in the Jag1 conditional/null mutant livers were related to extracellular matrix (ECM) interactions, cell adhesion and cell migration. One of the most highly up-regulated genes was Ddr1, encoding a receptor tyrosine kinase (RTK) belonging to a large RTK family. We have found extensive co-localization of Jag1 and Ddr1 in bile ducts and blood vessels in postnatal liver. In addition, co-immunoprecipitation data provide evidence for a novel protein interaction between Jag1 and Ddr1. Further studies will be required to define the nature of this interaction and its functional consequences, which may have significant implications for bile duct remodeling and repair of liver injury.

Indexed as

Alagille SyndromeAnimalsAzo CompoundsBile DuctsBlotting, WesternCalcium-Binding ProteinsDiscoidin Domain Receptor 1Extracellular MatrixFluorescent Antibody TechniqueImmunoprecipitationIntercellular Signaling Peptides and ProteinsJagged-1 ProteinLiverMembrane ProteinsMiceMice, KnockoutAzo CompoundsCalcium-Binding ProteinsDdr1 protein, mouseDirect Red 81Discoidin Domain Receptor 1Intercellular Signaling Peptides and ProteinsJag1 protein, mouseJagged-1 ProteinMembrane ProteinsReceptor Protein-Tyrosine KinasesSerrate-Jagged Proteins

Identifiers

PMID24391948
PMCPMC3877299
OpenAlexW2019362270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.